NDAQ vs CME

For growth investors, Nasdaq, Inc.

(NDAQ) is the stronger pick with 11. 1% revenue growth year-over-year, versus 6. 4% for CME Group Inc. (CME). CME Group Inc. (CME) offers the better valuation at 25. 8x trailing P/E (23. 6x forward), making it the more compelling value choice. Analysts rate Nasdaq, Inc. (NDAQ) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, CME Group Inc.

(CME) is the cheapest at 25. 8x versus Nasdaq, Inc. at 28. 9x. On forward P/E, Nasdaq, Inc. is actually cheaper at 22. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CME Group Inc. wins at 1. 72x versus Nasdaq, Inc. 's 2. 12x — a reasonable growth-adjusted valuation.

Over the past 5 years, Nasdaq, Inc.

(NDAQ) delivered a total return of +71. 7%, compared to +64. 1% for CME Group Inc. (CME). Over 10 years, the gap is even starker: NDAQ returned +351. 9% versus CME's +291. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CME Group Inc.

(CME) is the lower-risk stock at -0. 30β versus Nasdaq, Inc. 's 0. 78β — meaning NDAQ is approximately -358% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 81% for Nasdaq, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Nasdaq, Inc.

(NDAQ) is pulling ahead at 11. 1% versus 6. 4% for CME Group Inc. (CME). On earnings-per-share growth, the picture is similar: Nasdaq, Inc. grew EPS 60. 1% year-over-year, compared to 15. 4% for CME Group Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CME Group Inc.

(CME) is the more profitable company, earning 62. 0% net margin versus 21. 8% for Nasdaq, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 28. 4% for NDAQ. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, CME Group Inc. (CME) is the more undervalued stock at a PEG of 1. 72x versus Nasdaq, Inc. 's 2. 12x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Nasdaq, Inc. (NDAQ) trades at 22. 7x forward P/E versus 23. 6x for CME Group Inc. — 0. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NDAQ: 28. 5% to $114. 60.

All stocks in this comparison pay dividends.

CME Group Inc. (CME) offers the highest yield at 3. 8%, versus 1. 2% for Nasdaq, Inc. (NDAQ).

For long-horizon retirement investors, CME Group Inc.

(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 30), 3. 8% yield, +291. 2% 10Y return). Both have compounded well over 10 years (CME: +291. 2%, NDAQ: +351. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: NDAQ is a mid-cap quality compounder stock; CME is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.